{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T03:43:47Z","timestamp":1769831027072,"version":"3.49.0"},"reference-count":49,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Cardiol."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.2217\/fca-2020-0153","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T16:38:19Z","timestamp":1611074299000},"page":"1249-1260","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["How I Treat statin-associated Side Effects in an Outpatient Setting"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3581-3832","authenticated-orcid":false,"given":"Vishnu Priya","family":"Pulipati","sequence":"first","affiliation":[{"name":"Preventive Cardiology Section of Cardiology The University of Chicago 5841 S Maryland Avenue MC 6080 B-608A\r          Chicago\r          IL\r          60637\r          USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H","family":"Davidson","sequence":"additional","affiliation":[{"name":"Preventive Cardiology Section of Cardiology The University of Chicago 5841 S Maryland Avenue MC 6080 B-608A\r          Chicago\r          IL\r          60637\r          USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.04.052"},{"key":"e_1_3_2_4_1","first-page":"4","volume-title":"Dyslipidemia.","author":"Wengrofsky P","year":"2019","unstructured":"Wengrofsky P , LeeJ, MakaryusAN. Dyslipidemia and its role in the pathogenesis of atherosclerotic cardiovascular disease: implications for evaluation and targets for treatment of dyslipidemia based on recent guidelines. In: Dyslipidemia.McFarlaneSI (Ed.), IntechOpen, NY, USA, 4\u20137 (2019)."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-15-1-23"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.036"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308537"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.15629"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1298-5"},{"issue":"25","key":"e_1_3_2_10_1","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy S","year":"2019","unstructured":"Grundy S , StoneN, BaileyAet al. AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation, 139(25), e1082\u2013e1143 (2019).","journal-title":"Circulation"},{"issue":"3","key":"e_1_3_2_11_1","first-page":"117","article-title":"Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease","volume":"22","author":"Gu J","year":"2019","unstructured":"Gu J , YinZF, PanJAet al. Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease. Anatol. J. Cardiol., 22(3), 117\u2013124 (2019).","journal-title":"Anatol. J. Cardiol."},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2016.05.010"},{"issue":"6","key":"e_1_3_2_13_1","first-page":"631","article-title":"Statin therapy: review of safety and potential side effects","volume":"32","author":"Ramkumar S","year":"2016","unstructured":"Ramkumar S , RaghunathA, RaghunathS. Statin therapy: review of safety and potential side effects. Acta Cardiol. Sin., 32(6), 631\u2013639 (2016).","journal-title":"Acta Cardiol. Sin."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.036"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATV.0000000000000073"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-0670-z"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2016.05.002"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.03.019"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.06.049"},{"issue":"44","key":"e_1_3_2_21_1","first-page":"748","article-title":"Treatment options for statin-associated muscle symptoms","volume":"112","author":"Laufs U","year":"2015","unstructured":"Laufs U , ScharnaglH, HalleM, WindlerE, EndresM, M\u00e4rzW. Treatment options for statin-associated muscle symptoms. Dtsch Arztebl Int., 112(44), 748\u2013755 (2015).","journal-title":"Dtsch Arztebl Int."},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.575678"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2017-000438"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.12.037"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.02.011"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2016.01.003"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.03.004"},{"key":"e_1_3_2_28_1","unstructured":"American College of Cardiology . Statin intolerance tool. http:\/\/tools.acc.org\/StatinIntolerance\/#!\/"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0838"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/1715163518768534"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2014.02.010"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R509"},{"key":"e_1_3_2_33_1","unstructured":"US Food and Drug Administration . Drugs @FDA: FDA-approved drugs. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/"},{"key":"e_1_3_2_34_1","unstructured":"Wolters Kluwer . UpToDate: drug information (lexicomp). https:\/\/www.uptodate.com\/"},{"key":"e_1_3_2_35_1","unstructured":"Merck\/Schering-Plough Pharmaceuticals Inc. ZETIA\u00ae package insert. USA"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1410489"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.039415"},{"key":"e_1_3_2_38_1","unstructured":"Regeneron Pharmaceuticals Inc. PRALUENT\u00ae package insert. USA."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/2047487320941987"},{"key":"e_1_3_2_40_1","unstructured":"Amgen Inc. REPATHA\u2122 package insert. USA."},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615664"},{"key":"e_1_3_2_42_1","unstructured":"Esperion Therapeutics Inc. NEXLETOL\u2122 package insert. USA."},{"key":"e_1_3_2_43_1","unstructured":"Esperion Therapeutics Inc . Esperion announces positive top-line results from final pivotal Phase III study of bempedoic acid (2018). https:\/\/investor.esperion.com\/node\/10236\/pdf"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13457"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01101-9"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.08.006"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3608"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570161118666200807114559"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.2314"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.06.002"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01101-9"}],"container-title":["Future Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fca-2020-0153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:42:35Z","timestamp":1715956955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fca-2020-0153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.2217\/fca-2020-0153"],"URL":"https:\/\/doi.org\/10.2217\/fca-2020-0153","relation":{},"ISSN":["1479-6678","1744-8298"],"issn-type":[{"value":"1479-6678","type":"print"},{"value":"1744-8298","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifca20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifca20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}